Misplaced Pages

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 09:01, 25 November 2011 (Updating {{drugbox}} (changes to verified fields - added verified revid - updated 'ChEBI_Ref') per Chem/Drugbox validation (report errors or bugs)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Mitobronitol

Clinical data
ATC code	L01AX01 (WHO)
Identifiers
IUPAC name 1,6-dibromo-1,6-dideoxy-D-mannitol
CAS Number	488-41-5
PubChem CID	656655
ChemSpider	571004
UNII	5UP30YED7N
KEGG	D02020
ChEMBL	ChEMBL447629
CompTox Dashboard (EPA)	DTXSID3048158 DTXSID7022918, DTXSID3048158
ECHA InfoCard	100.006.979
Chemical and physical data
Formula	C6H12Br2O4
Molar mass	307.97 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES BrC(O)(O)(O)(O)CBr
InChI InChI=1S/C6H12Br2O4/c7-1-3(9)5(11)6(12)4(10)2-8/h3-6,9-12H,1-2H2/t3-,4-,5-,6-/m1/s1 Key:VFKZTMPDYBFSTM-KVTDHHQDSA-N
(what is this?)  (verify)

Mitobronitol (1,6-dibromo-1,6-dideoxy-D-mannitol) is a brominated analog of mannitol. It is an anticancer drug that is classified as an alkylating agent.

References

1. Mitobronitol, The Centre for Cancer Education

This antineoplastic or immunomodulatory drug article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Organobromides
• DNA replication inhibitors
• Monosaccharide derivatives
• Antineoplastic and immunomodulating drug stubs